Asker Healthcare Group AB (publ) (STO:ASKER)
Sweden · Delayed Price · Currency is SEK 78.40
+1.85 (2.42%)
Jul 28, 2026, 5:29 PM CET
Asker Healthcare Group AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 30,030 | 32,328 | - | - | - | - | |
Market Cap Growth | -22.77% | - | - | - | - | - |
Enterprise Value | 35,770 | 37,291 | 0 | 0 | 0 | 0 |
Last Close Price | 78.40 | 84.40 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 42.01 | 67.52 | - | - | - | - |
Forward PE | 25.52 | 28.98 | - | - | - | - |
PEG Ratio | 1.42 | 1.45 | - | - | - | - |
PS Ratio | 1.67 | 1.93 | - | - | - | - |
PB Ratio | 4.28 | 4.93 | - | - | - | - |
P/FCF Ratio | 30.18 | 24.34 | - | - | - | - |
P/OCF Ratio | 19.77 | 24.34 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.99 | 2.22 | - | - | - | - |
EV/EBITDA Ratio | 30.26 | 36.96 | - | - | - | - |
EV/EBIT Ratio | 30.26 | 36.96 | - | - | - | - |
EV/FCF Ratio | 35.95 | 28.08 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.71 | 0.75 | 1.53 | 1.50 | 1.60 | 1.86 |
Debt / EBITDA Ratio | 5.48 | 5.76 | 6.17 | 4.41 | 6.70 | 6.07 |
Debt / FCF Ratio | 4.27 | 4.38 | 4.86 | 4.73 | 4.86 | 9.50 |
Net Debt / Equity Ratio | 0.82 | 0.75 | 1.58 | 1.52 | 1.64 | 1.75 |
Net Debt / EBITDA Ratio | 4.82 | 4.89 | 5.66 | 4.07 | 6.40 | 5.24 |
Net Debt / FCF Ratio | 3.75 | 3.71 | 4.46 | 4.36 | 4.64 | 8.21 |
Asset Turnover | 1.04 | 1.12 | 1.23 | 1.25 | 1.33 | 1.27 |
Inventory Turnover | 4.80 | 5.14 | 5.61 | 6.25 | 6.26 | 6.04 |
Quick Ratio | 0.77 | 0.76 | 0.74 | 0.77 | 0.82 | 1.02 |
Current Ratio | 1.31 | 1.36 | 1.40 | 1.40 | 1.53 | 1.76 |
Return on Equity (ROE) | 10.35% | 10.11% | 11.49% | 7.03% | 18.82% | 25.82% |
Return on Assets (ROA) | 5.38% | 5.22% | 5.32% | 3.57% | 6.23% | 7.02% |
Return on Invested Capital (ROIC) | 7.55% | 7.62% | 7.83% | 5.16% | 8.92% | 10.43% |
Return on Capital Employed (ROCE) | 9.05% | 8.91% | 10.51% | 7.03% | 10.35% | 10.53% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.38% | 1.48% | - | - | - | - |
FCF Yield | 3.31% | 4.11% | - | - | - | - |
Dividend Yield | 0.51% | 0.00% | - | - | - | - |
Payout Ratio | 21.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Buyback Yield / Dilution | -13.57% | -14.59% | -22.56% | -1.55% | -9.55% | - |
Total Shareholder Return | -13.07% | -14.59% | -22.56% | -1.55% | -9.55% | - |